Products Products
Mutual Funds
Stock Market
NPS Retirement Funds

Company Company
About us
Contact us
1000001415
Paytm
Mutual Funds Stock Market NPS Retirement Funds
About us Contact us

Bal Pharma

101.50
+2.15 (2.16%) tick BSE

Buy Sell

Last updated on 5 May 2025 03:34 PM

Returns
-4.25%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

158.17

Earning Per Share

6.5

Dividend Yield

1.31%

P/E Ratio

14.04

P/B Ratio

1.48

Debt to Equity

1.28

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Bal Pharma Ltd (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May '87. In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.

Similar Companies


Login